Volume : 09, Issue : 07, July – 2022
Title:
52.FORMULATION, DEVELOPMENT AND EVALUATION OF TAZAROTENE INVASOME GEL FOR TREATMENT OF TOPICAL DISEASE
Authors :
Pragya Sharma*, Priyanka Namdeo, Dr. Govind Nayak, Dr. Parul Mehta
Abstract :
In the tropics, infectious diseases that either occurs exclusively or more frequently in humid and subtropical climates are either more prevalent or more difficult to prevent or manage. A type of vesicular system called invasomes exhibits greater transdermal penetration than conventional liposomes. These vesicles’ structures contain phospholipids, ethanol, and terpene, which provide the soft vesicles good transdermal penetration properties. These nanovesicles’ ability to increase drug permeability into the epidermis while reducing absorption into the systemic circulation, hence restricting drug action within the skin layer, is one of its main advantages. In present study was to develop and characterize Tazarotene -loaded invasomal drug carrier systems. Different Formulations (F1 to F6) of invasomes were prepared and evaluated for average vesicle size, zeta potential and entrapment efficiency.Drug content of Tazarotene incorporated invasomes gel for formulation TIG-1, TIG-2 and TIG-3 was found to be97.85±0.32, 99.12±0.25 and 98.74±0.14 respectively. The maximum drug content was found in formulation TIG-2 (99.12±0.25), select as optimized formulation.When the regression coefficient values of were compared, it was observed that ‘r2’ values of Higuchi was maximum i.e.0.994 hence indicating drug release from formulations was found to follow Higuchi kinetics.
Key words: Invasome, Tazarotene , Topical disease, Formulation, Evaluation
Cite This Article:
Please cite this article in press Pragya Sharmaet al,Formulation, Development And Evaluation Of Tazarotene Invasome Gel For Treatment Of Topical Disease.,Indo Am. J. P. Sci, 2022; 09(7).,
Number of Downloads : 10
References:
1. Meunier YA, Hole M, Shumba T, Swanner BJ. Tropical Diseases: A Practical Guide for Medical Practitioners and Students. OUP USA, 2013; 1-106.
2. Chen M, Liu X, Fahr A. Skin penetration and deposition of carboxyfluoresce in and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application. Int. J. Pharm. 2011; 408: 223–234.
3. Ota Y, Hamada A, Nakano M, Saito, H. Evaluation of percutaneous absorption of midazolambyterpenes. Drug Metab. Pharmacokinet. 2003, 18, 261–266.
4. Puglia C, Bonina F, Trapani G, Franco M, Ricci M. Evaluation of in vitro percutaneous absorption of lorazepam and clonazepam from hydro-alcoholic gel formulations. Int. J. Pharm. 2001; 228: 79–87.
5. Vaddi H, Ho P, Chan Y, Chan S. Terpenes in ethanol: Haloperidol permeation and partition through human skin and stratum corneum changes. J. Control. Release. 2002; 81: 121–133.
6. Verma D, Verma S, McElwee K, Freyschmidt-Paul P, Hoffman R, Fahr A. Treatment of alopecia areata in the DEBR model using Cyclosporin Alipidvesicles. Eur. J. Dermatol. 2004; 14:332–338.
7. Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: Characterization, stability and in vitro skin penetration studies. Colloids Surf B Biointerfaces 2009; 70:198-206.
8. Dragicevic-Curic N, Gräfe S, Gitter B, Fahr A. Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines. J PhotochemPhotobiol B 2010; 101:238-50.
9. Badran MM, Kuntsche J, Fahr A. Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: Dependency on needle size and applied formulation. Eur J Pharm Sci 2009; 36:511-23.
10. Haag SF, Fleige E, Chen M, Fahr A, Teutloff C, Bittl R, et al. Skin penetration enhancement of core-multishellnanotransporters and invasomes measured by electron paramagnetic resonance spectroscopy. Int J Pharm 2011; 416:223-8.
11. Ayman F. El-Kattan, Charles S. Asbill, Nanhye Kim, Bozena B. Michniak. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. International Journal of Pharmaceutics. 2001; 215: 229 ă 240.
12. Kalpana B, Lakshmi P K. Transdermal permeation enhancement of Tolterodine tartrate through invasome and iontophoresis. Der Pharmacia Lettre, 2013; 5(6): 119 – 126.
13. Multimer MN, Riffskin C, Hill JA, Marry E, Cyr NG and Glickman GJ. Synthesis of methylsilyl derivatives of procaine and their diffusion. J Am Pharm Assoc. Sci, 1956; 45: 212.
14. Aqil M, Ahad A, Sultana Y, Ali A. 2007. Status of terpenes as skin penetration enhancers. Drug Discov Today. 12:1061–1067.
15. Mohamed M.I., Makky A.M., Abdellatif M.M., Liposomal Gel as Carriers for Safer Topical Delivery of Tazarotene. Journal of Pharmaceutical Research and Opinion 2013; 3: 1182 – 90.